Current Medical Research and Opinion and online now on Taylor 
   & Francis Online 


   Rivaroxaban: particular conditions of prescription in Murcia and 
   Alicante, Spain 
   Re: Martinez CC, Cerezo Manchado JJ, Flores Blanco PJ, et al. 
   Effectiveness and safety of rivaroxaban in nonvalvular atrial 
   fibrillation: data from a contemporary Spanish registry. Curr Med Res 
   Opin. 2019. https://doi.org/10.1080/03007995.2019.1600483 
   Gabriel Cismaru 
   Pages: 1-1 
   DOI: 10.1080/03007995.2019.1626165 
   https://www.tandfonline.com/action/doSecureKeyLogin?uuid=d8594a82-ce8d-4e6c-8a1f-0da062c12f34&dateTime=201907160810&key=0IZ7idTNiX72lEQU2U%2BDgcNR5Yi1sg%2FZl8lyNuTC958%3D&uri=https%3A%2F%2Fwww.tandfonline.com%2Fdoi%2Fabs%2F10.1080%2F03007995.2019.1626165%3Fai%3D1vr0d%26ui%3D843fx%26af%3DT 

   Novel adipocytokines and lipodystrophic syndromes 
   Despina D. Briana & Ariadne Malamitsi-Puchner 
   Pages: 1-1 
   DOI: 10.1080/03007995.2019.1625637 
   https://www.tandfonline.com/action/doSecureKeyLogin?uuid=d8594a82-ce8d-4e6c-8a1f-0da062c12f34&dateTime=201907160810&key=0IZ7idTNiX72lEQU2U%2BDgcNR5Yi1sg%2FZl8lyNuTC958%3D&uri=https%3A%2F%2Fwww.tandfonline.com%2Fdoi%2Fabs%2F10.1080%2F03007995.2019.1625637%3Fai%3D1vr0d%26ui%3D843fx%26af%3DT 

   VITALITY: impact of adalimumab on health and disability outcomes in 
   patients with Crohn’s disease, rheumatoid arthritis, or psoriasis 
   treated in clinical practice in New Zealand 
   Richard B. Gearry, Christopher Frampton, Stephen Inns, David 
   Poppelwell, Marius Rademaker & Ravi Suppiah 
   Pages: 1-10 
   DOI: 10.1080/03007995.2019.1634952 
   https://www.tandfonline.com/action/doSecureKeyLogin?uuid=d8594a82-ce8d-4e6c-8a1f-0da062c12f34&dateTime=201907160810&key=0IZ7idTNiX72lEQU2U%2BDgcNR5Yi1sg%2FZl8lyNuTC958%3D&uri=https%3A%2F%2Fwww.tandfonline.com%2Fdoi%2Fabs%2F10.1080%2F03007995.2019.1634952%3Fai%3D1vr0d%26ui%3D843fx%26af%3DT 

   Healthcare resource utilization and associated cost analysis of the 
   PROCLAIM study in patients with stage III non-small-cell lung cancer 
   Ramaswamy Govindan, Suresh Senan, Nicolas Dickgreber, Mariano 
   Provencio, Yi-Long Wu, Konstantinos Syrigos, Barbara Parente, Michele 
   Wilson, Ryan Ziemiecki, Nadia Chouaki, Anwar Hossain, Belén San 
   Antonio, Katherine Winfree & Everett E. Vokes 
   Pages: 1-7 
   DOI: 10.1080/03007995.2019.1623185 
   https://www.tandfonline.com/action/doSecureKeyLogin?uuid=d8594a82-ce8d-4e6c-8a1f-0da062c12f34&dateTime=201907160810&key=0IZ7idTNiX72lEQU2U%2BDgcNR5Yi1sg%2FZl8lyNuTC958%3D&uri=https%3A%2F%2Fwww.tandfonline.com%2Fdoi%2Fabs%2F10.1080%2F03007995.2019.1623185%3Fai%3D1vr0d%26ui%3D843fx%26af%3DT 

   Efficacy and safety of mirogabalin for the treatment of fibromyalgia: 
   results from three 13-week randomized, double-blind, placebo- and 
   active-controlled, parallel-group studies and a 52-week open-label 
   extension study 
   Lesley M. Arnold, Susan Whitaker, Ching Hsu, David Jacobs & Domenico 
   Merante 
   Pages: 1-11 
   DOI: 10.1080/03007995.2019.1629757 
   https://www.tandfonline.com/action/doSecureKeyLogin?uuid=d8594a82-ce8d-4e6c-8a1f-0da062c12f34&dateTime=201907160810&key=0IZ7idTNiX72lEQU2U%2BDgcNR5Yi1sg%2FZl8lyNuTC958%3D&uri=https%3A%2F%2Fwww.tandfonline.com%2Fdoi%2Fabs%2F10.1080%2F03007995.2019.1629757%3Fai%3D1vr0d%26ui%3D843fx%26af%3DT